Hannah Valantine's Net Worth
Hannah Valantine's net worth is estimated to be at least $591,396.65 as of 07/06/2025. CoreStreet's estimation of Hannah Valantine's net worth is based on their sale of stock and current holding of stock.
Hannah Valantine is Director at BridgeBio Pharma Inc. They have executed at least 4 trades of stock as per SEC Form 4 filings. Their most recent trade was for 2,418 units of BBIO stock on 06/26/2025. Their biggest sale was on 06/18/2025 when they sold 10,570 units of Caredx Inc stock for $202,521.20. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $591,396.65
Most recent insider trade:
- June 26, 2025
Hannah Valantine's Insider Trading History
| BridgeBio Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 26, 2025 | Director | 2,418 | $44.05 | Sell | $106,512.90 |
June 10, 2025 | Director | 4,292 | $40.00 | Sell | $171,680.00 |
Jan. 16, 2024 | Director | 2,915 | $37.97 | Sell | $110,682.55 |
| Caredx Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 18, 2025 | Director | 10,570 | $19.16 | Sell | $202,521.20 |